Search Contract Opportunities

FDA Preventive maintenance-repair service for Thermo Altis-Vanquish tandem system

ID: 75F40126Q134224 • Type: Synopsis Solicitation • Match:  90%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

This requirement is for a base period and 4 option periods of preventive maintenance and repair service for a Thermo Altis MS-Vanquish HPLC tandem instrument syste. Please see attached PDF file titled FDA 75F40126134224.

Background
The Food and Drug Administration (FDA) is seeking a contractor to provide preventive maintenance and repair services for the Thermo Altis MS-Vanquish HPLC tandem instrument system. This requirement includes a base period and four option periods, emphasizing the importance of maintaining operational efficiency for critical laboratory equipment.

Work Details
The contractor will be responsible for:

1. Performing preventive maintenance on the Thermo Altis MS-Vanquish HPLC tandem system according to the manufacturer's specifications.

2. Providing repair services as needed to ensure the system remains operational.

3. Ensuring compliance with Section 508 accessibility standards for all ICT supplies and services provided under this contract.

4. Submitting an Accessibility Conformance Report (ACR) for any items not in compliance with Section 508 standards, detailing evaluation methods used for validation.

5. Conducting inspections and accepting supplies/services at the destination as specified by the Contracting Officer's Representative (COR).

Period of Performance
The geographic location(s) the contract will be performed (if provided)

Place of Performance
Services will be performed at FDA facilities as specified in the contract.

Bidder Requirements
Bidders must demonstrate verifiable prior experience providing maintenance and support for OEM equipment, including qualifications of field service engineers/technicians. They must also provide a detailed Accessibility Conformance Report (ACR) based on the Voluntary Product Accessibility Template (VPAT) for any non-compliant items. Additionally, bidders must certify compliance with Section 508 requirements and provide documentation of their pricing structure.
Loading Map
Loading Map

Overview

Response Deadline
June 23, 2026, 3:00 p.m. EDT Due in 8 Days
Posted
June 15, 2026, 9:05 a.m. EDT
Set Aside
None
Place of Performance
Silver Spring, MD 20993 United States
Source

Current SBA Size Standard
$34 Million
Est. Level of Competition
Low
Est. Value Range
Experimental
$75,000 - $175,000 (AI estimate)
Signs of Shaping
The solicitation is open for 8 days, below average for the Food and Drug Administration.
On 6/15/26 Food and Drug Administration issued Synopsis Solicitation 75F40126Q134224 for FDA Preventive maintenance-repair service for Thermo Altis-Vanquish tandem system due 6/23/26. The opportunity was issued full & open with NAICS 811210 and PSC J066.
Primary Contact
Name
Tim Walbert   Profile
Phone
(301) 796-1768

Documents

Posted documents for Synopsis Solicitation 75F40126Q134224

Opportunity Assistant


AI Analysis

AI Generate

Incumbent or Similar Awards

Contracts Similar to Synopsis Solicitation 75F40126Q134224

Potential Bidders and Partners

Awardees that have won contracts similar to Synopsis Solicitation 75F40126Q134224

Similar Active Opportunities

Open contract opportunities similar to Synopsis Solicitation 75F40126Q134224

Experts for FDA Preventive maintenance-repair service for Thermo Altis-Vanquish tandem system

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
June 15, 2026
Last Updated By
timothy.walbert@fda.hhs.gov
Archive Date
July 8, 2026